Cellular proliferation in pilocytic and diffuse astrocytomas

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 1, 1999, Pages 46-53

  Giannini, C ^a   Scheithauer, B W ^a,b   Burger, P C ^c   Christensen, M R ^a   Wollan, P C ^a   Sebo, T J ^a   Forsyth, P A ^b   Hayostek, C J ^b  

^a Dept of Lab Medicine and Pathology ^*  (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE CELL NECROSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032944497     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199901000-00006     Document Type: Article

References (40)

1. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization, Sobin LH, ed. Second ed. Berlin-Heidelberg-New York: Springer-Verlag, 1993
2. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: A simple and reproducible method. Cancer 1988;62: 2152-65
3. Tomlison FH, Scheithauer BW, Hayosteck CJ, et al.The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum - A clinico-pathologic and flow cytometric study. J Child Neurol 1994;9:301-10
4. Evans N. Mitotic figures in malignant tumors as affected by time before fixation of tissues. Arch Pathol 1926;1:894-98
5. Bullough WS. Mitotic activity in the tissues of dead mice, and in tissues kept in physiological salt solutions. Exp Cell Res 1950;1: 410-20
6. Scully RE, Kempson RI, Norris HJ. Mitosis counting. Hum Pathol 1976;7:481-84
7. Montironi RY, Collan Y, Scarpelli M, et al. Reproducibility of mitotic counts and identification of mitotic figures in malignant glial tumors. Appl Pathol 1988;6:258-65
8. Coons SW, Pearl DK. Mitosis identification in diffuse gliomas: Implications for tumor grading. Cancer (in press)
9. Gerdes JU, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20
10. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation - Associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15
11. Morimura T, Kitz K, Budka H. In situ analysis of cell kinetics in human brain tumors: A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine - Labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol 1989;77:276-82
12. Khoshyomn SH, Maier T, Morimura T, Kitz K, Budka H. Immunostaining for proliferating cell nuclear antigen: Its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol 1993;86:582-89
13. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-26
14. Sallinen PK, Haapasalo HK, Visakorpi T, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994;174:275-82
15. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 1986;10:611-17
16. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 1987;74:179-82
17. Zuber P, Hamou MF, de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988;22:364-68
18. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study. Acta Neuropathol 1991;81:675-79
19. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T. Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 1993;71: 199-206
20. Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-79
21. Coons SW, Johnson PC, Ki-67/MIB-1 labeling index predicts patient survival in low grade and anaplastic astrocytomas [abstract]. J Neuropathol Exp Neurol 1996;55:656
22. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996;77:373-80
23. Hsu DW, Louis DN, Efird JT, Hedley-Whyte ET. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 1997;56:857-65
24. Kiss R, Dewitte O, Decaestecker C, et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 1997;107:321-31
25. MacKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greenberg HS, Junck L. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters J Neuropathol Exp Neurol 1997;56:798-805
26. Pollack IF, Campbell JW, Hamilton RL, Martinez AJ, Bozik ME. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer 1997;79:849-56
27. Kirkegaard LJ, DeRose PB, Yao B, Cohen C. Image cytonietric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas: Prognostic significance. Am J Clin Pathol 1998;109: 69-74
28. Cattoretti G, Becker MHG, Key G. et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168: 357-63
29. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathol 1993;22:355-60
30. Forsyth PA, Shaw EG, Scheithauer BW, O'Fallon JR, Layton Jr. DD, Katzmann JA. Supratentorial pilocytic astrocytomas: A clinicopathologic, prognostic, and flow cytonietric study of 51 patients. Cancer 1993;72:1335-42
31. Hayostek CJ, Shaw EG, Scheithauer B, et al. Astrocytomas of the cerebellum: A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 1993;72: 856-69
32. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 1991;74:27-37
33. Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas DGT. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 1993;116:781-93
34. Sebo TJ. Digital image analysis. Mayo Clin Proc 1995;70: 81-82
35. Giannini C, Wollan P, Scheithauer BW, Sebo TJ, Hill E, Plummer T. The MIB-1 labeling index: A critical assessment of staining and quantification methods. Abstract presented at the US-Canadian IAP, 1997
36. Burger PC, Scheithauer BW, Lee RA, O'Neill BP. An interdisciplinary approach to avoid overtreatment of central nervous system lesions. Cancer 1997;80:2040-46
37. Coons SW, Johnson PC. Regional heterogeneity of DNA content of human gliomas. Cancer 1993;72:3052-60
38. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993;52:609-18
39. Glantz MJ, Burger PC, Herndon JE, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-44
40. Daumas Duport C. Histologic grading of gliomas. Curr Opin Neurol Neurosurg 1992;5:924-31